Top Markets
Coin of the day
Arch Biopartners Inc. Arch Biopartners Inc.

Arch Biopartners Inc.

ARCH
Kedudukan dalam Saham #25415
Arch Biopartners Inc. is a biotechnology firm dedicated to devising... Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
Harga Saham
$0.73393689
Disegerakkan terakhir: 2026-08-20
Modal Pasaran
$49.86M
Perubahan (1 hari)
-8.26%
Perubahan (1 tahun)
-38.15%
Negara
CA
Perdagangan Arch Biopartners Inc. (ARCH)

Kategori

Sejarah harga saham bagi Arch Biopartners Inc. (ARCH)
Harga penutupan tertinggi: $0.80 pada 2026-08-01

Harga penutupan terendah: $0.24 pada 2010-05-01
Sejarah harga saham Arch Biopartners Inc. dari 2010 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -23.16%
2025 -30.82%
2024 20.19%
2023 -48.03%
2022 -33.91%
2021 176.41%
2020 54.21%
2019 -26.71%
2018 185.93%
2017 8.76%
2016 42.45%
2015 -21.16%
2014 48.45%
2013 -6.69%
2012 -40.44%
2011 -46.45%
2010 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$758.49 8.17%
CH
$130.43 397.46%
US